Incidental Mutation 'IGL01662:Acvr2b'
ID 103212
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Acvr2b
Ensembl Gene ENSMUSG00000061393
Gene Name activin receptor IIB
Synonyms ActRIIB
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # IGL01662
Quality Score
Status
Chromosome 9
Chromosomal Location 119231184-119264061 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to C at 119261570 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Tyrosine to Histidine at position 388 (Y388H)
Ref Sequence ENSEMBL: ENSMUSP00000126108 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000035093] [ENSMUST00000165044] [ENSMUST00000215746]
AlphaFold P27040
Predicted Effect probably damaging
Transcript: ENSMUST00000035093
AA Change: Y380H

PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
SMART Domains Protein: ENSMUSP00000035093
Gene: ENSMUSG00000061393
AA Change: Y380H

DomainStartEndE-ValueType
Pfam:Activin_recp 27 117 5.4e-13 PFAM
transmembrane domain 130 152 N/A INTRINSIC
Pfam:Pkinase 206 494 1.5e-55 PFAM
Pfam:Pkinase_Tyr 206 494 2.3e-26 PFAM
Predicted Effect probably damaging
Transcript: ENSMUST00000165044
AA Change: Y388H

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000126108
Gene: ENSMUSG00000061393
AA Change: Y388H

DomainStartEndE-ValueType
Pfam:Activin_recp 27 117 5.3e-14 PFAM
transmembrane domain 138 160 N/A INTRINSIC
Pfam:Pkinase_Tyr 214 502 1.7e-26 PFAM
Pfam:Pkinase 217 501 1e-31 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000213389
Predicted Effect noncoding transcript
Transcript: ENSMUST00000213431
Predicted Effect probably damaging
Transcript: ENSMUST00000215746
AA Change: Y364H

PolyPhen 2 Score 0.997 (Sensitivity: 0.41; Specificity: 0.98)
Predicted Effect noncoding transcript
Transcript: ENSMUST00000217621
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. [provided by RefSeq, Jul 2008]
PHENOTYPE: Mice homozygous for targeted mutations that inactivate the gene show abnormal lateral asymmetry and homeotic transformation of the axial skeleton, and die shortly after birth with extensive cardiac defects. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 38 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Acsm5 A T 7: 119,137,511 (GRCm39) I402F probably damaging Het
Adh1 G A 3: 137,988,512 (GRCm39) D162N possibly damaging Het
C6 G T 15: 4,822,236 (GRCm39) R585I probably damaging Het
Ccdc169 T A 3: 55,070,732 (GRCm39) probably null Het
Cdh13 T A 8: 119,401,916 (GRCm39) M106K probably damaging Het
Cep78 C T 19: 15,938,359 (GRCm39) E530K probably damaging Het
Cyfip1 T A 7: 55,546,487 (GRCm39) L533Q probably damaging Het
Etl4 T C 2: 20,811,460 (GRCm39) V1181A probably benign Het
Galnt7 T G 8: 57,984,769 (GRCm39) probably benign Het
Gm11595 G A 11: 99,663,498 (GRCm39) R61C unknown Het
Gucy1a1 T A 3: 82,016,560 (GRCm39) I143F possibly damaging Het
Hmcn1 T C 1: 150,613,050 (GRCm39) N1410D possibly damaging Het
Ltbp2 G A 12: 84,856,020 (GRCm39) T741I probably benign Het
Mdc1 T C 17: 36,163,397 (GRCm39) S982P probably benign Het
Mfsd4b2 A G 10: 39,798,193 (GRCm39) probably benign Het
Mrgprb5 T G 7: 47,818,172 (GRCm39) I188L probably benign Het
Naip6 T A 13: 100,436,862 (GRCm39) S554C probably damaging Het
Nav2 A G 7: 49,220,957 (GRCm39) N1715D probably damaging Het
Nav3 A T 10: 109,605,119 (GRCm39) S985T possibly damaging Het
Nme7 A G 1: 164,155,866 (GRCm39) Q22R probably benign Het
Or52i2 T C 7: 102,319,927 (GRCm39) W267R probably damaging Het
Otulinl C T 15: 27,658,151 (GRCm39) D290N probably damaging Het
Pabir1 A G 19: 24,453,948 (GRCm39) V258A probably benign Het
Ppp1r9a A G 6: 5,115,322 (GRCm39) E815G probably damaging Het
Ppp2r2c T A 5: 37,083,744 (GRCm39) I95N probably damaging Het
Ppp4r4 G A 12: 103,569,225 (GRCm39) E717K possibly damaging Het
Prdm2 A G 4: 142,860,138 (GRCm39) S1051P possibly damaging Het
Rnf214 T C 9: 45,811,084 (GRCm39) D193G probably damaging Het
Sirpb1b G T 3: 15,608,244 (GRCm39) T167K probably damaging Het
Slc16a3 C A 11: 120,847,532 (GRCm39) S240* probably null Het
Snx14 T A 9: 88,267,891 (GRCm39) probably benign Het
Sorbs2 A G 8: 46,256,866 (GRCm39) probably benign Het
Stk-ps2 A T 1: 46,068,522 (GRCm39) noncoding transcript Het
Taar7b A T 10: 23,875,874 (GRCm39) D13V probably benign Het
Trp53bp1 T C 2: 121,066,506 (GRCm39) E740G probably damaging Het
Unc79 C T 12: 103,115,279 (GRCm39) A2054V possibly damaging Het
Zfp106 A G 2: 120,354,034 (GRCm39) V211A probably benign Het
Zfp112 A G 7: 23,825,379 (GRCm39) H449R probably benign Het
Other mutations in Acvr2b
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL02206:Acvr2b APN 9 119,257,064 (GRCm39) nonsense probably null
IGL03022:Acvr2b APN 9 119,256,587 (GRCm39) missense probably benign 0.10
IGL03131:Acvr2b APN 9 119,260,350 (GRCm39) missense possibly damaging 0.92
R0455:Acvr2b UTSW 9 119,261,675 (GRCm39) missense probably damaging 1.00
R2131:Acvr2b UTSW 9 119,261,874 (GRCm39) missense probably damaging 1.00
R4744:Acvr2b UTSW 9 119,260,328 (GRCm39) missense probably damaging 1.00
R5278:Acvr2b UTSW 9 119,261,555 (GRCm39) missense probably damaging 0.99
R5636:Acvr2b UTSW 9 119,257,375 (GRCm39) missense probably damaging 1.00
R6196:Acvr2b UTSW 9 119,262,469 (GRCm39) missense possibly damaging 0.71
R6253:Acvr2b UTSW 9 119,257,627 (GRCm39) missense probably damaging 1.00
R6424:Acvr2b UTSW 9 119,231,645 (GRCm39) missense probably benign
R6465:Acvr2b UTSW 9 119,262,369 (GRCm39) missense probably damaging 1.00
R7096:Acvr2b UTSW 9 119,257,255 (GRCm39) splice site probably null
R7102:Acvr2b UTSW 9 119,261,619 (GRCm39) missense probably damaging 0.96
R7497:Acvr2b UTSW 9 119,262,352 (GRCm39) missense probably benign
R8557:Acvr2b UTSW 9 119,261,654 (GRCm39) missense probably damaging 0.98
R9041:Acvr2b UTSW 9 119,257,052 (GRCm39) nonsense probably null
R9149:Acvr2b UTSW 9 119,257,116 (GRCm39) missense probably damaging 1.00
R9276:Acvr2b UTSW 9 119,231,616 (GRCm39) missense probably benign 0.23
R9321:Acvr2b UTSW 9 119,257,351 (GRCm39) missense probably benign 0.01
R9340:Acvr2b UTSW 9 119,257,492 (GRCm39) missense probably damaging 0.98
R9531:Acvr2b UTSW 9 119,260,392 (GRCm39) missense probably benign 0.00
Posted On 2014-01-21